We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
82 hedge funds and large institutions have $117M invested in Puma Biotechnology in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
287% more call options, than puts
Call options by funds: $843K | Put options by funds: $218K
217% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 6
93% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 15
73% more capital invested
Capital invested by funds: $67.6M → $117M (+$49.2M)
19% more funds holding
Funds holding: 69 → 82 (+13)
2.62% more ownership
Funds ownership: 54.1% → 56.73% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
82
Holders Change
+13
Holders Change %
+18.84%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
19
Increased
29
Reduced
15
Closed
6
Calls
$843K
Puts
$218K
Net Calls
+$625K
Net Calls Change
-$188K
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.62M |
| 2 |
Morgan Stanley
New York
|
+$1.37M |
| 3 |
Man Group
London,
United Kingdom
|
+$559K |
| 4 |
Jane Street
New York
|
+$456K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$445K |
